Results 21 to 30 of about 1,186,610 (361)

Duration of antithyroid drug treatment may predict weight gain after radioactive iodine therapy in patients with Graves’ disease

Heliyon, 2022
Background: Weight gain post-radioiodine (RAI) treatment is observed in patients with hyperthyroid Graves’ disease. Previous studies, mostly in Caucasian patients, demonstrated excessive weight gain averaging 5–7 kg from initial presentation.
Thewjitcharoen Yotsapon, Chatchomchuan Waralee, Prasatkaew Hussamon, Srichomchey Panita, Butadej Siriwan, Nakasatien Soontaree, Wanothayaroj Ekgaluck, Rajatanavin Rajata, Himathongkam Thep   +8 more
doaj   +1 more source

Distribution and dynamics of Tc-99m-pertechnetate uptake in the thyroid and other organs assessed by single-photon emission computed tomography in living mice [PDF]

, 2010
Background: Tc-99m pertechnetate is a well-known anion, used for clinical imaging of thyroid function. This gamma emitter is transported by the sodium iodide symporter but is not incorporated into thyroglobulin. Scintigraphy using Tc-99m pertechnetate or
Darcourt, Jacques, Defrise, Michel, Franken, Philippe R, Guglielmi, Julien, Koulibaly, Malick, Pourcher, Thierry, Vanhove, Christian   +6 more
core   +1 more source

Subclinical thyroid dysfunction and cognitive decline in old age [PDF]

, 2013
<p>Background: Subclinical thyroid dysfunction has been implicated as a risk factor for cognitive decline in old age, but results are inconsistent. We investigated the association between subclinical thyroid dysfunction and cognitive decline in the
Liselotte W. Wijsman, Anton J. M. de Craen, Stella Trompet, Jacobijn Gussekloo, David J. Stott, Nicolas Rodondi, Paul Welsh, J. Wouter Jukema, Rudi G. J. Westendorp, Simon P. Mooijaart, Paula Soares, MI Surks, IM Bensenor, G Ceresini, J Gussekloo, E Hogervorst, S Kalmijn, LM Roberts, MP van Boxtel, IP Casserly, R Luboshitzky, S Stabouli, WJ Hueston, AM Kanaya, JP Walsh, AR Cappola, AE Hak, N Rodondi, J Auer, CT Sawin, J Shepherd, S Trompet, I Klein, D Nanchen, JJ Diez, PJ Houx, R Jorde, J Parle, AJ Camm, PW Ladenson, G Waldemar, J Klubo-Gwiezdzinska, RP Peeters, A Pinchera, AW Weverling-Rijnsburger, CJ Packard, T van Bemmel, S Trompet, SP Mooijaart   +48 more
core   +10 more sources

miR-576-5p Promotes the Proliferation of Papillary Thyroid Carcinoma through the MAPK4-AKT Pathway

International Journal of Analytical Chemistry, 2022
Background. MicroRNA-576-5p (miR-576-5p) plays an important role in different human cancers. However, the biological function of miR-576-5p in papillary thyroid carcinoma (PTC) is still unclear.
Rui Hai, Yang Zhou, Fan Li, Qingxi Guo, Yang Long, Fang Wang, Lian Cheng, Fei Wu, Shi Chen, Xiangyu Zhou   +9 more
doaj   +1 more source

Segmentation of ultrasound images of thyroid nodule for assisting fine needle aspiration cytology [PDF]

, 2012
The incidence of thyroid nodule is very high and generally increases with the age. Thyroid nodule may presage the emergence of thyroid cancer. The thyroid nodule can be completely cured if detected early.
Tian, Hua, Zhang, Li, Zhao, Jie, Zheng, Wei   +3 more
core   +2 more sources

lncRNA MIR503HG Targets miR-191-5p/PLCD1 Axis and Negatively Modulates Apoptosis, Extracellular Matrix Disruption, and Inflammation in Abdominal Aortic Aneurysm

Mediators of Inflammation, 2023
As the most prevalent subtype of aortic aneurysm, abdominal aortic aneurysm (AAA) features the apoptosis, extracellular matrix (ECM) disruption, and inflammation response of vascular smooth muscle cells (VSMCs).
Ye Tian, Xinxi Li, Chao Bai, Zhenwei Yang, Lei Zhang, Jun Luo, Wenbin Zhang   +6 more
doaj   +1 more source

TERT Promoter Mutations in Papillary Thyroid Microcarcinomas [PDF]

, 2015
Small papillary thyroid carcinomas have contributed to the worldwide increased incidence of differentiated thyroid cancer observed over the past decades.
Bruno, Rocco, Casadei, Gianpaolo, Ciarrocchi, Alessia, Costante, Giuseppe, de Biase, Dario, Durante, Cosimo, Eszlinger, Markus, Filetti, Sebastiano, Frasoldati, Andrea, Gandolfi, Greta, Gugnoni, Mila, Paschke, Ralf, Pession, Annalisa, Piana, Simonetta, Ragazzi, Moira, Sancisi, Valentina, Tallini, Giovanni, Torlontano, Massimo, Visani, Michela   +18 more
core   +1 more source

Risk Factor Analysis and Prediction of Severe Hypocalcemia after Total Parathyroidectomy without Auto-Transplantation in Patients with Secondary Hyperparathyroidism

International Journal of Endocrinology, 2023
Objective. Our study aimed to develop and validate a nomogram to predict severe hypocalcemia (SH) before total parathyroidectomy (TPTX) without auto-transplantation in patients with secondary hyperparathyroidism. Methods.
Chenchen He, Yibing Zhang, Longfei Li, Guangming Cheng, Wei Zhang, Yufu Tang, Chunhui Wang   +6 more
doaj   +1 more source

Impact of first-line treatment choice on long-term outcomes of hyperthyroid Graves’ disease patients with thyrotoxic periodic paralysis

Journal of Clinical & Translational Endocrinology, 2020
Background: Thyrotoxic periodic paralysis (TPP) is a unique manifestation of Graves’ disease. While it is uncommon in Asian, it is extremely rare in Caucasian patients (0.1–0.2%).
Krittadhee Karndumri, Yotsapon Thewjitcharoen, Waralee Chatchomchuan, Sriurai Porramatikul, Sirinate Krittiyawong, Ekgaluck Wanothayaroj, Siriwan Butadej, Soontaree Nakasatien, Rajata Rajatanavin, Thep Himathongkam   +9 more
doaj   +1 more source

Unmodifiable variables related to thyroid cancer incidence [PDF]

, 2018
The incidence of thyroid cancer is significantly different between male and female patients. Thyroid cancer is also the only form of cancer where age can be considered a staging variable.
Alecu, Lucian, Hainarosie, Razvan, Jecan, Radu C., Nitipir, Cornelia, Orlov, Cristina, Pituru, Silviu, Slavu, Iulian, Stanculeanu, Dana L., Stoian, Anca P., Tulin, Adrian, Tulin, Raluca   +10 more
core   +2 more sources